• DSS board and majority shareholders acted by written consent to clear issuance of securities that could shift control to Alset International Limited.
• Consent authorizes issuance of more than 19.99% of outstanding common stock, up to 19,864,866 shares, to satisfy NYSE American listing rules tied to securities purchase agreement dated March 26, 2026.
• Transaction documents call for Alset International Limited to loan USD 2.45 million via a convertible promissory note at 3% interest, convertible at USD 0.74 per share, alongside warrants for 16,554,055 shares at USD 0.93.
• Full conversion and warrant exercise would leave Alset International Limited with 20,933,175 shares, about 70% of outstanding common stock.
• Action expected to take effect on or about June 3, 2026, at least 20 days after information statement mailing dated May 14, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dss Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-023075), on May 14, 2026, and is solely responsible for the information contained therein.